CEO Angotti Vincent J. Buys $85K in Talphera Stock, Receives Significant Option Grant
TLPH has more than doubled off its 52-week low of $0.38 on light trading volume (0.2× avg).
Summary
Talphera's CEO, Vincent J. Angotti, made an open market purchase of $85,587 in company stock and received a grant of 594,000 stock options, indicating strong insider conviction.
Key Events · Ownership and Investor Activity · TLPH
-
CEO Open Market Purchase
CEO Vincent J. Angotti acquired 105,364 shares of common stock in an open market transaction valued at $85,587.18 on February 12, 2026.
-
Significant Option Grant
The CEO was granted options to purchase 594,000 shares of common stock on February 12, 2026, with an exercise price of $0.8123, vesting over time to further align his interests with shareholders.
-
Ongoing Insider Accumulation
This purchase contributes to a pattern of insider accumulation, with over $93,000 in net open market buys by three insiders in the last 90 days, signaling collective confidence.
Analysis · TLPH · Life Sciences
Talphera's CEO, Vincent J. Angotti, demonstrated strong conviction by making an open market purchase of over $85,000 in company stock. This direct investment, combined with a substantial grant of 594,000 stock options, significantly aligns his personal financial interests with the company's performance. This activity contributes to a broader pattern of insider accumulation, suggesting a positive internal outlook for the nano-cap company.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.3% of the 1065 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TLPH was trading at $0.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $36.2M. The 52-week trading range was $0.38 to $1.57. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.